BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carnero E, Fortes P. HCV infection, IFN response and the coding and non-coding host cell genome. Virus Res 2016;212:85-102. [PMID: 26454190 DOI: 10.1016/j.virusres.2015.10.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Saleh NA, Elhaes H, Ibrahim M. Design and Development of Some Viral Protease Inhibitors by QSAR and Molecular Modeling Studies. Viral Proteases and Their Inhibitors. Elsevier; 2017. pp. 25-58. [DOI: 10.1016/b978-0-12-809712-0.00002-2] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Valadkhan S, Fortes P. Regulation of the Interferon Response by lncRNAs in HCV Infection. Front Microbiol 2018;9:181. [DOI: 10.3389/fmicb.2018.00181] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
3 Fortes P, Morris KV. Long noncoding RNAs in viral infections. Virus Res 2016;212:1-11. [PMID: 26454188 DOI: 10.1016/j.virusres.2015.10.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 7.6] [Reference Citation Analysis]
4 Carnero E, Barriocanal M, Prior C, Pablo Unfried J, Segura V, Guruceaga E, Enguita M, Smerdou C, Gastaminza P, Fortes P. Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication. EMBO Rep 2016;17:1013-28. [PMID: 27283940 DOI: 10.15252/embr.201541763] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]
5 Suarez B, Prats-Mari L, Unfried JP, Fortes P. LncRNAs in the Type I Interferon Antiviral Response. Int J Mol Sci 2020;21:E6447. [PMID: 32899429 DOI: 10.3390/ijms21176447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
6 Shi R, Cui Y. Global analysis of a mathematical model for Hepatitis C virus transmissions. Virus Research 2016;217:8-17. [DOI: 10.1016/j.virusres.2016.02.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Valadkhan S, Gunawardane LS. lncRNA-mediated regulation of the interferon response. Virus Res 2016;212:127-36. [PMID: 26474526 DOI: 10.1016/j.virusres.2015.09.023] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
8 Unfried JP, Fortes P. LncRNAs in HCV Infection and HCV-Related Liver Disease. Int J Mol Sci 2020;21:E2255. [PMID: 32214045 DOI: 10.3390/ijms21062255] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
9 Barriocanal M, Fortes P. Long Non-coding RNAs in Hepatitis C Virus-Infected Cells. Front Microbiol. 2017;8:1833. [PMID: 29033906 DOI: 10.3389/fmicb.2017.01833] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
10 Barriocanal M, Prior C, Suarez B, Unfried JP, Razquin N, Hervás-Stubbs S, Sangro B, Segura V, Fortes P. Long Noncoding RNA EGOT Responds to Stress Signals to Regulate Cell Inflammation and Growth. J Immunol 2021;206:1932-42. [PMID: 33789981 DOI: 10.4049/jimmunol.1900776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Fortes P, Morris KV. Long noncoding RNAs in viral infections. Virus Res. 2016;212:1-11. [PMID: 26454188 DOI: 10.1016/j.virusres.2015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Fan XC, Liu TL, Wang Y, Wu XM, Wang YX, Lai P, Song JK, Zhao GH. Genome-wide analysis of differentially expressed profiles of mRNAs, lncRNAs and circRNAs in chickens during Eimeria necatrix infection. Parasit Vectors 2020;13:167. [PMID: 32245514 DOI: 10.1186/s13071-020-04047-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
13 Saleh NA, Elshemey WM. Structure-based drug design of novel peptidomimetic cellulose derivatives as HCV-NS3 protease inhibitors. Life Sci 2017;187:58-63. [PMID: 28842311 DOI: 10.1016/j.lfs.2017.08.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]